Beckman Coulter Life Sciences and Illumina Enter Into Application Development Agreement for the Biomek NGeniuS System

INDIANAPOLIS – (February 16, 2022) – Beckman Coulter Life Sciences continues to work with chemistry companies seeking collaborations to develop applications for the Biomek NGeniuS Next Generation Library Preparation System ahead of its launch. An application development agreement has been signed with Illumina, a developer of solutions for the sequencing and analysis of genomes, to develop new applications on the Biomek NGeniuS System*.

The Biomek NGeniuS System is a purpose-built liquid handler for next generation sequencing (NGS) library preparation. It provides an easy-to-use automation solution that reduces manual transfers and hands-on time for the traditionally labor-intensive process of NGS library construction. Hands-on time is reduced by innovations which include a reagent input carousel to minimize the manual transfer of reagents, along with an integrated thermal cycler and labware transport system.

“We’re honored that companies continue to turn to Beckman Coulter Life Sciences and put their trust in us,” said Jason Lanie, Vice President and General Manager of the company’s Biotechnology Business Unit. “This is another strong reinforcement of the value we bring to labs and that we’re able to provide a high-performance next generation sequencing solution, further accelerating NGS library prep through purpose-built systems.”

“We are pleased to collaborate with Beckman Coulter Life Sciences, with its deep automation expertise, to expand laboratory access to our NGS-based oncology and genetic disease testing research,” said Joydeep Goswami, Chief Strategy and Corporate Development Officer of Illumina. “Automating in-house testing will reduce turn-around times, improve customer experience, and ultimately enable laboratories to quickly provide relevant, actionable results to healthcare researchers.”

As part of this agreement, Illumina will develop applications specifically designed for the Biomek NGeniuS liquid handler, which will be available to Biomek NGeniuS System users via a first-of-its-kind electronic application library.

The Biomek NGeniuS System is scheduled to launch in the second quarter of 2022. More product information, resources, and previews can be found at

About Beckman Coulter Life Sciences

Life sciences. Research. Precision manufacturing. If your life’s calling is in any of these or related fields, you need to know Beckman Coulter Life Sciences. Our mission is to empower those seeking answers to life’s important scientific and healthcare questions. Since 1935, the Beckman name has been synonymous with technologies that simplify and automate complex biomedical testing. Decades later, our global organization also came to embody the scientific legacy of the Coulter name. Today, Beckman Coulter Life Sciences is a trusted, worldwide resource for tools to help optimize research and manufacturing efficiency. Centrifuges. Particle counters/analyzers. Automated liquid handlers. Flow cytometers. Genomic reagents. All these products—and many more—continue to make a difference in people’s lives by improving the productivity of dedicated scientists, quality control experts and others. Wherever people need answers, from prestigious universities and major pharmaceutical companies, to small biotech startups, food/beverage and electronics manufacturing facilities, you can find Beckman Coulter Life Sciences. For more details, visit

*  Not intended or validated for use in diagnosis of disease or other conditions. The Biomek NGeniuS Next Generation Library Prep System is in development; performance characteristics have not been validated.

Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

Contact: Matt McCutcheon, Global External Communications Manager
317-719-0557 [email protected]